This inventor holds 3 USPTO granted patents. Top assignee: Academia Sinica. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2024
Title: Pei-Yi Su: Innovator in Antimicrobial Peptides
Introduction
Pei-Yi Su is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of antimicrobial peptides, holding a total of 3 patents. His work focuses on developing innovative solutions to combat microbial infections.
Latest Patents
Pei-Yi Su's latest patents include a modified antimicrobial peptide derived from an arginine-rich domain. This antimicrobial peptide comprises 2 to 20 variable domains, each consisting of 2 to 20 consecutive basic amino acids. The variable domains are separated by a variable linker, which can contain 1 to 20 amino acids that are not two or more consecutive basic amino acids. Importantly, the peptide has a maximum length of 100 amino acids. Another significant patent involves antimicrobial peptides derived from the hepatitis B virus core protein arginine-rich domain. This pharmaceutical composition includes an isolated peptide with three or four arginine-rich domains from the carboxy-terminal region of the hepatitis B virus core protein, exhibiting antimicrobial activity, along with a pharmaceutically acceptable carrier.
Career Highlights
Pei-Yi Su is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to explore and innovate in the field of antimicrobial research, contributing to advancements in medical science.
Collaborations
Pei-Yi Su collaborates with esteemed colleagues, including Chiaho Shih and Heng-Li Chen. These collaborations enhance the research and development of new antimicrobial solutions.
Conclusion
Pei-Yi Su's innovative work in antimicrobial peptides showcases his dedication to advancing medical science. His patents reflect a commitment to finding effective solutions against microbial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
